Humana (HUM)
(Delayed Data from NYSE)
$254.47 USD
+7.12 (2.88%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $254.60 +0.13 (0.05%) 5:32 PM ET
4-Sell of 5 4
A Value C Growth A Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Humana Inc. has a market cap of $29.75B, which represents its share price of $247.35 multiplied by its outstanding shares number of 120.27M. As a large-cap company, HUM's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
HUM 254.47 +7.12(2.88%)
Will HUM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HUM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HUM
Centene Loses 57% YTD, Incurs Loss in Q2: How to Play the Stock
Why Humana (HUM) is a Top Momentum Stock for the Long-Term
HUM: What are Zacks experts saying now?
Zacks Private Portfolio Services
HUM Misses Q2 Earnings on Higher Benefit Costs, Ups '25 EPS View
Here's What Key Metrics Tell Us About Humana (HUM) Q2 Earnings
CVS Health Care Delivery: Will the Growth Momentum Last in Q2?
Other News for HUM
Medicare insurers rise as Wolfe points to favorable CAHPS survey cutpoints
Protean Funds Scandinavia AB July 2025 Partner Letter
Notable healthcare headlines for the week: Trump’s ultimatum to big pharma, Novo Nordisk, UnitedHealth and Moderna in focus
Barclays Raises Price Target for Humana (HUM) to $275 | HUM Stock News
Humana (HUM) Target Price Lowered by Morgan Stanley | HUM Stock News